NOS1 upregulates ABCG2 expression contributing to DDP chemoresistance in ovarian cancer cells
Open Access
- 3 December 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (2) , 1595-1602
Abstract
Nitric oxide synthase 1 (NOS1) has been reported to promote various cancer processes including chemoresistance. However, the role of NOS1 in chemoresistance has remained unclear. ATP‑binding cassette, subfamily G, member 2 (ABCG2) has been identified as a molecular cause of multidrug resistance in a number of cancer types, including ovarian cancer. The present study observed that in ovarian cancer cells, the expression of ABCG2 was significantly upregulated in response to cis‑diamminedichloroplatinum (cisplatin/DDP) treatment, in addition the expression of NOS1 exhibited an increasing trend. Additionally, the levels of NOS1 and ABCG2 in chemoresistant ovarian cancer profiles in Gene Expression Omnibus datasets (GSE26712 and GSE51373) were higher than in chemosensitive profiles. Furthermore, overexpression of NOS1 could upregulate ABCG2 expression, and expression of ABCG2 was inhibited by NOS1 selective inhibitor (N‑PLA). In assays of cell survival, NOS1 appeared to increase the potential for DDP resistance, and this effect was reversed by addition of ABCG2 inhibitor (verapamil). The present study indicated that NOS1‑induced chemoresistance was partly mediated by the upregulation of ABCG2 expression. This result suggests a link between the expression of NOS1 and the ABCG2‑associated chemoresistance in ovarian cancer.Keywords
This publication has 31 references indexed in Scilit:
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- The role of nitric oxide in tumour progressionNature Reviews Cancer, 2006
- [Nitric oxide in malignant astrocytes].2005
- Nitric oxide signaling in colon cancer chemopreventionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Grading Ovarian Serous Carcinoma Using a Two-Tier SystemAmerican Journal of Surgical Pathology, 2004
- The role of nitric oxide in cancerCell Research, 2002
- NO‐Mediated Chemoresistance in C6 Glioma CellsAnnals of the New York Academy of Sciences, 2002
- Nitric Oxide-Mediated Regulation of Chemosensitivity in Cancer CellsJNCI: Journal of the National Cancer Institute, 2001
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Role of nitric oxide in carcinogenesis and tumour progressionThe Lancet Oncology, 2001